Retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab for carcinoma of the buccal mucosa with N3 lymph node metastasis: a case report

Oral Radiol. 2019 Jan;35(1):77-83. doi: 10.1007/s11282-018-0319-y. Epub 2018 Feb 5.

Abstract

We herein report a case of squamous cell carcinoma of the buccal mucosa with N3 cervical lymph node metastasis in a 63-year-old man. The patient was treated with combination therapy comprising radiotherapy (2 Gy/day, total of 70 Gy), superselective intra-arterial chemotherapy via a superficial temporal artery (docetaxel, total of 70 mg/m2 and cisplatin, total of 175 mg/m2), cetuximab (initial dose of 400 mg/m2 with subsequent weekly doses of 250 mg/m2 intravenously), and four sessions of hyperthermia for cervical lymph node metastases. The patient responded well to the therapy, with a complete response of the primary tumor. Radical neck dissection was performed with reconstructive surgery, including resection of the overlying skin. A pathologic complete response was achieved for the N3 and all other cervical lymph node metastases. The patient showed no evidence of recurrence in the 3 years following treatment. Based on the findings in the present case, the use of retrograde superselective intra-arterial chemoradiotherapy combined with hyperthermia and cetuximab seems to be a promising modality for patients with N3 cervical lymph node metastasis of oral cancer.

Keywords: Cetuximab; Hyperthermia; Intra-arterial chemoradiotherapy; N3 cervical lymph node metastasis; Oral cancer.

Publication types

  • Case Reports

MeSH terms

  • Cetuximab
  • Chemoradiotherapy
  • Humans
  • Hyperthermia, Induced*
  • Infusions, Intra-Arterial
  • Lymph Nodes
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Mouth Mucosa*
  • Mouth Neoplasms / therapy*
  • Neoplasm Recurrence, Local

Substances

  • Cetuximab